YB Medical Ltd 08641667 false 2022-08-26 2023-08-23 2023-08-23 The principal activity of the company is general medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 08641667 2022-08-26 2023-08-23 08641667 2023-08-23 08641667 core:CurrentFinancialInstruments 2023-08-23 08641667 core:CurrentFinancialInstruments core:WithinOneYear 2023-08-23 08641667 core:Non-currentFinancialInstruments core:AfterOneYear 2023-08-23 08641667 core:FurnitureFittingsToolsEquipment 2023-08-23 08641667 core:MotorVehicles 2023-08-23 08641667 bus:SmallEntities 2022-08-26 2023-08-23 08641667 bus:AuditExemptWithAccountantsReport 2022-08-26 2023-08-23 08641667 bus:FilletedAccounts 2022-08-26 2023-08-23 08641667 bus:SmallCompaniesRegimeForAccounts 2022-08-26 2023-08-23 08641667 bus:RegisteredOffice 2022-08-26 2023-08-23 08641667 bus:Director1 2022-08-26 2023-08-23 08641667 bus:PrivateLimitedCompanyLtd 2022-08-26 2023-08-23 08641667 core:FurnitureFittingsToolsEquipment 2022-08-26 2023-08-23 08641667 core:MotorVehicles 2022-08-26 2023-08-23 08641667 core:OfficeEquipment 2022-08-26 2023-08-23 08641667 core:OtherRelatedParties 2022-08-26 2023-08-23 08641667 countries:EnglandWales 2022-08-26 2023-08-23 08641667 2022-08-25 08641667 core:FurnitureFittingsToolsEquipment 2022-08-25 08641667 core:MotorVehicles 2022-08-25 08641667 2021-08-27 2022-08-25 08641667 2022-08-25 08641667 core:CurrentFinancialInstruments 2022-08-25 08641667 core:CurrentFinancialInstruments core:WithinOneYear 2022-08-25 08641667 core:Non-currentFinancialInstruments core:AfterOneYear 2022-08-25 08641667 core:FurnitureFittingsToolsEquipment 2022-08-25 08641667 core:MotorVehicles 2022-08-25 iso4217:GBP xbrli:pure

Registration number: 08641667

YB Medical Ltd

Unaudited Filleted Financial Statements

for the Period from 26 August 2022 to 23 August 2023

 

YB Medical Ltd

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 4

 

YB Medical Ltd

(Registration number: 08641667)
Balance Sheet as at 23 August 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

112,488

54,884

Current assets

 

Debtors

5

217,075

153,171

Cash at bank and in hand

 

7,265

39,193

 

224,340

192,364

Creditors: Amounts falling due within one year

6

(136,769)

(123,188)

Net current assets

 

87,571

69,176

Total assets less current liabilities

 

200,059

124,060

Creditors: Amounts falling due after more than one year

6

(199,281)

(162,154)

Net assets/(liabilities)

 

778

(38,094)

Capital and reserves

 

Called up share capital

200

200

Retained earnings

578

(38,294)

Shareholders' funds/(deficit)

 

778

(38,094)

For the financial period ending 23 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 26 July 2024 and signed on its behalf by:
 

.........................................
Dr Youssef Amal Beaini
Director

 

YB Medical Ltd

Notes to the Unaudited Financial Statements for the Period from 26 August 2022 to 23 August 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Auker Rhodes
Basement Floor
Focus House, Focus Way
Yeadon
LS19 7DB

These financial statements were authorised for issue by the Board on 26 July 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor vehicles

25% on Cost

Furniture,fitting and equipment

20% and 33.33% on Cost

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and
rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease
obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2 (2022 - 2).

 

YB Medical Ltd

Notes to the Unaudited Financial Statements for the Period from 26 August 2022 to 23 August 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 26 August 2022

18,031

86,663

104,694

Additions

-

93,500

93,500

At 23 August 2023

18,031

180,163

198,194

Depreciation

At 26 August 2022

17,311

32,499

49,810

Charge for the period

595

35,301

35,896

At 23 August 2023

17,906

67,800

85,706

Carrying amount

At 23 August 2023

125

112,363

112,488

At 25 August 2022

720

54,164

54,884

5

Debtors

Current

2023
£

2022
£

Other debtors

217,075

153,171

 

217,075

153,171

 

YB Medical Ltd

Notes to the Unaudited Financial Statements for the Period from 26 August 2022 to 23 August 2023

6

Creditors

Creditors: amounts falling due within one year

Note

2023
£

2022
£

Due within one year

 

Loans and borrowings

37,053

40,253

Trade creditors

 

4,800

4,700

Taxation and social security

 

-

284

Accruals and deferred income

 

4,900

4,800

Other creditors

 

90,016

73,151

 

136,769

123,188

Creditors: amounts falling due after more than one year

Note

2023
£

2022
£

Due after one year

 

Loans and borrowings

199,281

162,154

7

Related party transactions

Summary of transactions with other related parties

Dr Youssef Amal Beaini and Mrs Hannah Beaini
( Directors )

 There were no disclosable transactions in the year. At the balance sheet date the amount due from Dr Youssef Amal Beaini and Mrs Hannah Beaini was £92,783 (2022 - £107,658).